Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Elvin · SciRah

Researcher profile · Semantic Scholar

J. Elvin

Share profile

J. Elvin — researcher profile on SciRah

h-index: 54
Works: 375
Citations: 14K

Most-cited papers

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
E. Swisher, T. Kwan, A. Oza, A. Tinker +30 more
2021Nature Communications179 citations Open access
Semantic Scholar
Tumor Genomic Testing for >4000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib).
M. Hussain, C. Corcoran, Caroline Sibilla, K. Fizazi +21 more
2022Clinical Cancer Research97 citations Open access
Semantic Scholar
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases
R. Huang, J. Haberberger, E. Severson, D. Duncan +17 more
2020Modern Pathology97 citations Open access
Semantic Scholar
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy
J. Jacob, E. Ferry, L. Gay, J. Elvin +15 more
2019Journal of Urology85 citations
Semantic Scholar
A phase II evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability
S. Bellone, D. Roque, E. Siegel, N. Buza +29 more
2021Cancer71 citations Open access
Semantic Scholar
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design
J. Ross, E. Sokol, H. Moch, L. Mileshkin +8 more
2020The Oncologist67 citations Open access
Semantic Scholar
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
A. Necchi, R. Madison, D. Raggi, J. Jacob +19 more
2020European Urology58 citations
Semantic Scholar
Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
D. Lin, A. Hemmerich, C. Edgerly, D. Duncan +10 more
2020Gynecologic Oncology54 citations
Semantic Scholar
Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets
Erik A. Williams, Adrienne J. Werth, Radwa Sharaf, M. Montesion +19 more
2020JCO Precision Oncology51 citations Open access
Semantic Scholar
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)
S. Bellone, D. Roque, E. R. Siegel, N. Buza +29 more
2021Annals of Oncology45 citations Open access
Semantic Scholar
Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms
R. Eskander, J. Elvin, L. Gay, J. Ross +2 more
2020JCO Precision Oncology44 citations Open access
Semantic Scholar
Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma
R. Huang, J. Haberberger, K. Murugesan, N. Danziger +7 more
2021Modern Pathology41 citations Open access
Semantic Scholar
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.
A. Necchi, G. Bratslavsky, R. Corona, J. Chung +15 more
2020European Urology Focus41 citations
Semantic Scholar
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles
Erik A. Williams, N. Shah, M. Montesion, Radwa Sharaf +8 more
2020Modern Pathology41 citations Open access
Semantic Scholar
Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas
D. Lin, R. Huang, Douglas A. Mata, B. Decker +6 more
2021Modern Pathology38 citations Open access
Semantic Scholar
Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin
D. Lin, N. Shah, J. Tse, J. Killian +9 more
2020Gynecologic Oncology Reports37 citations Open access
Semantic Scholar
Brief Report: Calculating the Tumor Nuclei Content for Comprehensive Cancer Panel Testing.
Masashi Mikubo, K. Seto, A. Kitamura, Masato Nakaguro +13 more
2020Journal of Thoracic Oncology35 citations Open access
Semantic Scholar
Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors
L. Ramkissoon, W. Pegram, J. Haberberger, N. Danziger +23 more
2020Frontiers in Neurology28 citations Open access
Semantic Scholar
Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations
Erik A. Williams, M. Montesion, N. Shah, Radwa Sharaf +9 more
2020Modern Pathology27 citations Open access
Semantic Scholar
Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients.
R. Huang, Jinpeng Xiao, D. Pavlick, Cui Guo +16 more
2021Clinical Chemistry25 citations Open access
Semantic Scholar
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer
B. Hill, R. Graf, Kunal J. Shah, N. Danziger +9 more
2023International Journal of Gynecological Cancer24 citations Open access
Semantic Scholar
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer.
R. Huang, Xinyan Li, J. Haberberger, E. Sokol +28 more
2020The Oncologist24 citations Open access
Semantic Scholar
CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features
Erik A. Williams, M. Montesion, B. Alexander, S. Ramkissoon +7 more
2020Modern Pathology24 citations Open access
Semantic Scholar
Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.
D. Lin, A. Fine, N. Danziger, R. Huang +9 more
2022Gynecologic Oncology23 citations
Semantic Scholar
Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry
R. Huang, E. Severson, J. Haberberger, D. Duncan +24 more
2021Pathology and Oncology Research21 citations Open access
Semantic Scholar
Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary
D. Lin, J. Killian, J. Venstrom, S. Ramkissoon +2 more
2020Modern Pathology20 citations Open access
Semantic Scholar
Method of Tissue Acquisition Affects Success of Comprehensive Genomic Profiling in Lung Cancer.
Douglas A. Mata, L. Harries, Erik A. Williams, M. Hiemenz +17 more
2022Archives of Pathology & Laboratory Medicine17 citations Open access
Semantic Scholar
CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma
Erik A. Williams, M. Montesion, Radwa Sharaf, J. Corines +12 more
2020Modern Pathology15 citations Open access
Semantic Scholar
Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition
E. Severson, J. Haberberger, A. Hemmerich, R. Huang +14 more
2022The Oncologist13 citations Open access
Semantic Scholar
CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1–Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-Codeletion
Erik A. Williams, Radwa Sharaf, B. Decker, Adrienne J. Werth +13 more
2020JCO Precision Oncology13 citations Open access
Semantic Scholar
Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas
Nathan D. Seligson, Joy Tang, Dexter X. Jin, Monica P. Bennett +6 more
2022npj Precision Oncology12 citations Open access
Semantic Scholar
HPV51-associated Leiomyosarcoma
Erik A. Williams, M. Montesion, Vadim Lincoln, J. Tse +16 more
2022American Journal of Surgical Pathology12 citations Open access
Semantic Scholar
Comprehensive genomic profiling of histologic subtypes of urethral carcinomas.
J. Jacob, A. Necchi, P. Grivas, M. Hughes +29 more
2021Urologic oncology12 citations
Semantic Scholar
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit.
D. F. Hayes, R. Herbst, J. Myles, S. Topalian +22 more
2022JCO Precision Oncology11 citations Open access
Semantic Scholar
Next-generation sequencing (NGS) of tumor tissue from >4000 men with metastatic castration-resistant prostate cancer (mCRPC): The PROfound phase III study experience.
M. Hussain, J. Mateo, S. Sandhu, K. Fizazi +11 more
202011 citations
Semantic Scholar
Prevalence of High-Risk Nonvaccine Human Papillomavirus Types in Advanced Squamous Cell Carcinoma Among Individuals of African vs Non-African Ancestry
Erik A. Williams, J. Newberg, K. Williams, M. Montesion +3 more
2021JAMA Network Open10 citations Open access
Semantic Scholar
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas.
R. Huang, J. Haberberger, L. Harries, E. Severson +15 more
2021The Oncologist10 citations Open access
Semantic Scholar
Clinical Implications of Genomic Loss of Heterozygosity in Endometrial Carcinoma
B. Bustamante, Risha Sinha, B. Rice, A. Nizam +8 more
2021JCO Precision Oncology9 citations Open access
Semantic Scholar
Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
Erik A. Williams, N. Shah, N. Danziger, M. Montesion +6 more
2020Journal of American Academy of Dermatology8 citations Open access
Semantic Scholar
Liquid biopsy‐based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results
Douglas A. Mata, Jessica K. Lee, Vignesh Shanmugam, Chelsea B Marcus +15 more
2024Histopathology7 citations
Semantic Scholar
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers
D. Lin, R. Huang, I. Ladas, R. B. Keller +11 more
2024Frontiers in Oncology7 citations Open access
Semantic Scholar
PD-L1 gene amplification and focality: relationship with protein expression
D. Jardim, K. Murugesan, J. Elvin, R. Huang +1 more
2023Journal for ImmunoTherapy of Cancer7 citations Open access
Semantic Scholar
Endometrial Adenocarcinomas With No Specific Molecular Profile: Morphologic Features and Molecular Alterations of “Copy-number Low” Tumors
V. Meljen, Rhonda Mittenzwei, J. Wong, A. Puechl +9 more
2021International Journal of Gynecological Pathology7 citations Open access
Semantic Scholar
Primary versus metastatic intrahepatic cholangiocarcinoma: A comparative comprehensive genomic profiling (CGP) study.
J. Ross, E. Sokol, J. Vergilio, K. Killian +16 more
20206 citations
Semantic Scholar
A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors
J. Haberberger, Worthy Pegram, Nicholas Britt, Kelsie Schiavone +22 more
2023The Oncologist5 citations Open access
Semantic Scholar
NF2 mutation-driven renal cell carcinomas (RCC): A comprehensive genomic profiling (CGP) study.
E. Yakirevich, Carmen M. Perrino, A. Necchi, P. Grivas +15 more
20205 citations
Semantic Scholar
Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer
K. Murugesan, Dexter X. Jin, L. Comment, D. Fabrizio +11 more
2022The Oncologist3 citations Open access
Semantic Scholar
Racial differences in the mutational landscape of serous endometrial cancer.
J. Schink, R. Garg, B. Buttin, J. Elvin +6 more
2022Journal of Clinical Oncology3 citations
Semantic Scholar
TCF-001 TRACK (Target Rare Cancer Knowledge): A national patient-centric precision oncology trial for rare cancers.
V. Subbiah, R. Groisberg, Catherine M. Skefos, J. Cleary +13 more
20213 citations
Semantic Scholar
Acquired RB1 mutations in estrogen receptor-positive (ER+) clinically advanced and metastatic breast cancer (MBC).
K. McGregor, E. Sokol, N. Danziger, D. Pavlick +16 more
20203 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Ross×35
Invite
J. Ross — researcher profile on SciRah
S. Ramkissoon×28
Invite
S. Ramkissoon — researcher profile on SciRah
D. Lin×23
Invite
D. Lin — researcher profile on SciRah
E. Severson×19
Invite
E. Severson — researcher profile on SciRah

×19

Invite

B. Alexander — researcher profile on SciRah

Erik A. Williams×18

Invite

Erik A. Williams — researcher profile on SciRah

Invite

R. Huang — researcher profile on SciRah

J. Vergilio×16

Invite

J. Vergilio — researcher profile on SciRah

A. Hemmerich×15

Invite

A. Hemmerich — researcher profile on SciRah

N. Danziger×15

Invite

N. Danziger — researcher profile on SciRah

Invite

J. Killian — researcher profile on SciRah

J. Venstrom×13

Invite

J. Venstrom — researcher profile on SciRah